These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 30870804

  • 1. Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
    Arendt BM, Teterina A, Pettinelli P, Comelli EM, Ma DWL, Fung SK, McGilvray ID, Fischer SE, Allard JP.
    Nutrition; 2019 Jun; 62():100-107. PubMed ID: 30870804
    [Abstract] [Full Text] [Related]

  • 2. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    Garcia-Jaramillo M, Spooner MH, Löhr CV, Wong CP, Zhang W, Jump DB.
    PLoS One; 2019 Jun; 14(4):e0214387. PubMed ID: 30943218
    [Abstract] [Full Text] [Related]

  • 3. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids.
    Arendt BM, Comelli EM, Ma DW, Lou W, Teterina A, Kim T, Fung SK, Wong DK, McGilvray I, Fischer SE, Allard JP.
    Hepatology; 2015 May; 61(5):1565-78. PubMed ID: 25581263
    [Abstract] [Full Text] [Related]

  • 4. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E, Paul SB, Kedia S.
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [Abstract] [Full Text] [Related]

  • 5. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
    Zeng F, Zhang Y, Han X, Zeng M, Gao Y, Weng J.
    Front Immunol; 2020 Jan; 11():609900. PubMed ID: 33574818
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A, Cicciarelli G, Del Vecchio F, Gaggiano A, Verzella D, Fischietti M, Mastroiaco V, Vetuschi A, Sferra R, Barnabei R, Capece D, Zazzeroni F, Alesse E.
    BMC Cancer; 2016 Jan 05; 16():3. PubMed ID: 26728044
    [Abstract] [Full Text] [Related]

  • 7. Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.
    Pettinelli P, Arendt BM, Teterina A, McGilvray I, Comelli EM, Fung SK, Fischer SE, Allard JP.
    PLoS One; 2018 Jan 05; 13(10):e0205747. PubMed ID: 30379862
    [Abstract] [Full Text] [Related]

  • 8. NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.
    Caldwell S.
    Clin Mol Hepatol; 2017 Jun 05; 23(2):103-108. PubMed ID: 28494529
    [Abstract] [Full Text] [Related]

  • 9. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G, Li XP, Niu CY, Liu ML, Yan QQ, Fan LP, Li Y, Zhang KL, Gao J, Qian MR, He N, Mi M.
    Gene; 2020 Jun 05; 742():144549. PubMed ID: 32184169
    [Abstract] [Full Text] [Related]

  • 10. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
    Orime K, Shirakawa J, Togashi Y, Tajima K, Inoue H, Nagashima Y, Terauchi Y.
    Eur J Pharmacol; 2016 Feb 05; 772():22-32. PubMed ID: 26724391
    [Abstract] [Full Text] [Related]

  • 11. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
    Nogueira MA, Oliveira CP, Ferreira Alves VA, Stefano JT, Rodrigues LS, Torrinhas RS, Cogliati B, Barbeiro H, Carrilho FJ, Waitzberg DL.
    Clin Nutr; 2016 Jun 05; 35(3):578-86. PubMed ID: 26047766
    [Abstract] [Full Text] [Related]

  • 12. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
    Depner CM, Traber MG, Bobe G, Kensicki E, Bohren KM, Milne G, Jump DB.
    PLoS One; 2013 Jun 05; 8(12):e83756. PubMed ID: 24358308
    [Abstract] [Full Text] [Related]

  • 13. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
    Akuta N, Kawamura Y, Suzuki F, Saitoh S, Arase Y, Kunimoto H, Sorin Y, Fujiyama S, Sezaki H, Hosaka T, Kobayashi M, Suzuki Y, Kobayashi M, Ikeda K, Kumada H.
    Hepatol Int; 2016 Jul 05; 10(4):647-56. PubMed ID: 27074850
    [Abstract] [Full Text] [Related]

  • 14. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
    Walle P, Takkunen M, Männistö V, Vaittinen M, Lankinen M, Kärjä V, Käkelä P, Ågren J, Tiainen M, Schwab U, Kuusisto J, Laakso M, Pihlajamäki J.
    Metabolism; 2016 May 05; 65(5):655-666. PubMed ID: 27085774
    [Abstract] [Full Text] [Related]

  • 15. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Da Silva HE, Arendt BM, Noureldin SA, Therapondos G, Guindi M, Allard JP.
    J Acad Nutr Diet; 2014 Aug 05; 114(8):1181-94. PubMed ID: 24631112
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
    Barchetta I, Enhörning S, Cimini FA, Capoccia D, Chiappetta C, Di Cristofano C, Silecchia G, Leonetti F, Melander O, Cavallo MG.
    BMC Med; 2019 Apr 30; 17(1):85. PubMed ID: 31035998
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease is associated with heterogeneous pattern of fat infiltration in skeletal muscles.
    Nachit M, Dioguardi Burgio M, Abyzov A, Garteiser P, Paradis V, Vilgrain V, Leclercq I, Van Beers BE.
    Eur Radiol; 2024 Mar 30; 34(3):1461-1470. PubMed ID: 37658893
    [Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B, Qiao L, Hebbard L.
    World J Gastroenterol; 2016 Feb 28; 22(8):2494-502. PubMed ID: 26937137
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic fatty liver disease in HIV infection associated with altered hepatic fatty acid composition.
    Arendt BM, Mohammed SS, Ma DW, Aghdassi E, Salit IE, Wong DK, Guindi M, Sherman M, Heathcote EJ, Allard JP.
    Curr HIV Res; 2011 Mar 28; 9(2):128-35. PubMed ID: 21434863
    [Abstract] [Full Text] [Related]

  • 20. The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.
    Shimomura Y, Takaki A, Wada N, Yasunaka T, Ikeda F, Maruyama T, Tamaki N, Uchida D, Onishi H, Kuwaki K, Nakamura S, Nouso K, Miyake Y, Koike K, Tomofuji T, Morita M, Yamamoto K, Okada H.
    Intern Med; 2017 Mar 28; 56(3):243-251. PubMed ID: 28154266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.